Follow the ProNAi Therapeutics Inc share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 25 January 2016 (Levée d'options). Among the most active insiders: Rodigueza Wendi. All data is free.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
7 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ProNAi Therapeutics Inc is a biotechnology company focused on developing targeted therapies for cancer treatment. It utilizes a unique technology platform to design drugs based on oligonucleotides.